The changes of blood platelet activation in breast cancer patients before surgery, after surgery, and in various phases of the chemotherapy

Platelets

Volumn 24, Issue 6, 2013, Pages 462-468

  Kedzierska, Magdalena ^a   Czernek, Urszula ^b   Szydłowska Pazera, Katarzyna ^b   Potemski, Piotr ^b   Piekarski, Janusz ^b   Jeziorski, Arkadiusz ^b   Olas, Beata ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Aggregation; Blood platelets; Breast cancer; Chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; THROMBIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 84880862029     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.711866     Document Type: Article

References (36)

1. Goad KE, Gralnick HR. Coagulation disorders in cancer. Hematol/Oncol Clin North Am 1996;10:457-483.
2. Blann AD, Gurney D, Wadley M, Bareford D, Stonelake P, Lip GYH. Increased soluble P-selectin in patients with haematological and breast cancer: A comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor. Blood Coagul Fibrinol 2001;12:43-50.
3. Polek A, Sobiszewski W, Matowicka-Karna J. P-selectin and its role in some diseases. Postepy Hig Med Dosw 2009;19:465-470.
4. Gasic GJ. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metast Rev 1984;3:99-116.
5. Poggi A. Platelet-tumor cell interactions. Immunopharmacol 1995;8:151-165.
6. Heimoller E, Weinel RJ, Heidtmann HH, Salge U, Seitz R, Schmitz I, Muller KM, Zirngib L. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines. J Cancer Res Clin Oncol 1996;122:735-744.
7. Olas B, Wachowicz B. Role of reactive oxygen species in aggregation of blood platelets treated with cisplatin. Exp Clin Physiol Biochem 2002;4:29-35.
8. Kedzierska M, Olas B, Wachowicz B, Glowacki R, Bald E, Czernek U, Szyd-l owska-Pazera K, Potemski P, Piekarski J, Jeziorski A. Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy. Fitoterapia 2012;83:310-217.
9. Kȩdzierska M, Olas B, Wachowicz B, Stochmal A, Oleszek W, Jeziorski A, Piekarski J, Glowacki R. An extract from berries of Aronia melanocarpa modulates the generation of superoxide anion radicals in blood platelets from breast cancer patients. Planta Med 2009;75:1405-1409.
10. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001;86:298-307.
11. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64: 1057-1068.
12. Wachowicz B, Olas B, - Zbikowska HM, Buczyński A. Generation of reactive oxygen species in blood platelets. Platelets 2002;13:175-182.
13. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen - induced platelet activation. Blood 1998;91:484-490.
14. Olas B, -Zbikowska HM, Wachowicz B, Krajewski T, Buczyński A, Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Polon 1999;46:961-966.
15. Nowak P, Wachowicz B. Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets 2002;13:293-299.
16. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005;6:401-410.
17. Sousou T, Khorana AA. New insights into cancerassociated thrombosis. Arterioscler Thromb Vasc Biol 2009;29:316-320.
18. Kȩdzierska M, Olas B, Wachowicz B, Jeziorski A, Piekarski J. Relationship between thiol, tyrosine nitration and carbonyl formation as biomarkers of oxidative stress and changes of hemostatic function of plasma isolated from breast cancer patients before surgery. Clin Biochem 2012;45:231-236.
19. Olas B, Kȩdzierska M, Wachowicz B, Stochmal A, Oleszek W, Jeziorski A, Piekarski J, Glowacki R. Effect of aronia on thiol levels in plasma of breast cancer patients. Central Eur J Biol 2010;5:38-46.
20. Kȩdzierska M, Malinowska J, Glowacki R, Olas B, Bald E, Jeziorski A, Piekarshi J. The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients. Mol Cell Biochem 2011;355:193-199.
21. Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, Cooper P, Thompson D, Makris M. Hyperhomocysteinemia in women with advanced breast cancer. Int J Lab Hematol 2008;29:421-425.
22. Malinowska J, Nowak P, Olas B. Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma. Thromb Res 2011;127:214-219.
23. Dimitrova KR, Degroot KW, Suyderhoud JP, Pirovic EA, Murno TJ, Wieneke J, Myers AK, Kim YD. 17- Estradiol preserves endothelial cell viability in an in vitro model of homocysteine-induced oxidative stress. J Cardiovasc Pharmacol 2002;39:347-353.
24. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, De Pauw S. The thrombogenic effect of anticancer therapy in women with stage II breast cancer. N Eng J Med 1988;318:404-407.
25. Goodnough LT, Saito H, Manni A, Jones PK, Pearson OH. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer 1984;54:1264-1268.
26. Kim EJ, Lim KM, Noh JY, Kim K, Kang S, Chang YK, Shin S, Chung JH. Doxorubicin-induced platelet procaogulant activities: An important clue for chemotherapy-associated thrombosis. Toxicol Sci 2011;124:215-224.
27. Kȩdzierska M, Olas B, Wachowicz B, Stochmal A, Oleszek W, Jeziorski A, Piekarski J. The nitrative and oxidative stress in blood platelets isolated from breast cancer patients; the protectory action of Aronia melanocarpa extract. Platelets 2010;21: 541-548.
28. Kȩdzierska M, Olas B, Wachowicz B, Jeziorski A, Piekarski J. The lipid peroxidation in breast cancer patients. Gen Physiol Biophys 2010;29:208-210.
29. Keppler BK. Metal complexes in cancer chemotherapy. General remarks. In: Keppler BK, editor. Metal complexes in cancer chemotherapy. Weinheim, Germany: VCH; 1993. pp 1-8.
30. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40.
31. Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 2009;61:290-302.
32. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat Rev Drug Discov 2009;8:579-591.
33. Kim EJ, Lim KM, Kim KY, Bae ON, Noh JY, Chung SM, Shin S, Yun YP, Chung JH. Doxorubicin-induced platelet cytotoxicity: A new contributory factor for doxorubicin-mediated thrombocytopenia. J Thromb Haemost 2009;7:1172-1183.
34. Panis C, Herrera ACSA, Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Simao AN, Cechini AL, Cecchini R. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 2012;133:89-97.
35. Strumberg D, Brugge S, Korn MW, Koeppen S, Ranft J, Scheiber G, Reiners C, Mockel C, Seeber S, Scheulen ME. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 2002;13:229-236.
36. Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR, Cleton FJ, Osanto S. Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature. J Clin Oncol 2000;18:2169-2178.